TY - JOUR A2 - Ferraro, Giuseppe A. AU - Tissiani, L. A. L. AU - Alonso, N. PY - 2016 DA - 2015/12/28 TI - A Prospective and Controlled Clinical Trial on Stromal Vascular Fraction Enriched Fat Grafts in Secondary Breast Reconstruction SP - 2636454 VL - 2016 AB - 背景。脂肪移植是在二次乳房再造一个巨大的工具。间质血管部分（SVF）富含脂肪移植已提出关于卷维护可喜的成果。 方法。We developed a method that produces a superior SVF enrichment rate (2 : 1) in the operating theatre. This prospective and controlled trial analyzed quantitatively and qualitatively fat grafts with (stem cells group, SG) and without (control group, CG) SVF enrichment in secondary breast reconstruction, through MRI-based volumetry, immunophenotyping, and cell counting. Also, patient satisfaction, aesthetic outcomes, and complications were analyzed. 结果。在SG体积持久性是78,9％和51,4 CG％;但它并没有达到统计学显著差异。CD90是在SG中高度表达的唯一标记，并显示出与体积持久性正相关（ [R = 0.651 ， p = 0.03 ）。脂肪坏死发生的4例患者在SG和没有在CG。在CG患者表现为趋势更加满意。考虑到美观，这两个群体提出的改进。没有局部复发观察。 结论。尽管结果是令人鼓舞的，在一个更高的补充速度SVF富集没有改善，具有统计学意义，脂肪移植物体积的持久性。富含脂肪移植已被证明是在3年的随访安全。SN - 1687-966X UR - https://doi.org/10.1155/2016/2636454 DO - 10.1155 /二百六十三万六千四百五十四分之二千○一十六JF - 干细胞国际PB - Hindawi出版公司公司KW - ER -